Fatores associados à úlcera por pressão em pacientes internados nos Centros de Terapia Intensiva de Adultos

Trata-se de um estudo seccional analítico com o objetivo de estimar a ocorrência de úlceras por pressão e seus fatores associados em CTIs de adultos, em Belo Horizonte. A amostra foi constituída por 142 pacientes, com 18 anos ou mais, internados até as 24h do dia anterior à coleta de dados, em 316 leitos, distribuídos em 22 CTIs. A presença de pelo menos uma úlcera por pressão, e por paciente, foi de 35,2% (IC 95% = 27,4-47,7). Das 99 úlceras identificadas, constatou-se que foram mais frequentes nas regiões sacral (36,0%) e calcânea (22,0%). Observou-se que presença de sepses (OR = 6,04; IC 95% = 1,09-33,53), tempo de internação > 10 dias (OR = 7,61; IC 95% = 2,92-19,82) e risco alto e elevado na classificação da escala de Braden (OR = 4,96; IC 95% = 1,50-16,50) foram fatores independentes e significativamente associados à presença de úlcera por pressão. Conclui-se que sepses, tempo de internação e risco alto e elevado na classificação da escala de Braden são fatores potencialmente associados à formação de úlceras em pacientes acamados.

Smoking, prevalence of disease and health service utilization among the Swiss population.

The data of the 1981-83 Swiss National Health Survey "SOMIPOPS", based on a randomly selected sample of 4,235 individuals aged 20 or over representative of the whole Swiss population, were used to investigate the relation between smoking, prevalence of disease and frequency of health care utilization. The risks of several conditions, including hypertension, myocardial infarction and other heart diseases, asthma, tuberculosis and kidney disease were elevated among ex-smokers. The diseases showing elevated risks among current smokers and significantly positive dose-risk trends included acute bronchitis (relative risk, RR = 3.2 for heavy cigarette smokers vs never smokers), chronic bronchitis or lung emphysema (RR = 2.0), gastro-duodenal ulcer (RR = 1.8) and bone fractures (RR = 1.6). For respiratory conditions, the risk of pipe or cigar smokers was comparable to that of moderate cigarette smokers, whereas for ulcer (RR = 4.1) or fractures (RR = 2.0) the point estimates were even higher than for heavy cigarette smokers. Smokers tended to consult more frequently general practitioners, used more other outpatients services, and were more frequently admitted to hospital during the year preceding the interview. These effects were consistent across strata of age, socio-economic indicators, and persisted after allowance for major identified potential distorting factors. Thus, the results of this survey confirm that smoking is an important cause of morbidity and a major contributory factor to the use of health services.

HER2 shedding and serum HER2 extracellular domain: Biology and clinical utility in breast cancer.

The transmembrane protein HER2 is over-expressed in approximately 15% of invasive breast cancers as a result of HER2 gene amplification. HER2 proteolytic cleavage (HER2 shedding) generates soluble truncated HER2 molecules that include only the extracellular domain and the concentration of which can be measured in the serum fraction of blood. HER2 shedding also generates a constitutively active truncated intracellular receptor of 95kDa (p95(HER2)). Another soluble truncated HER2 protein (Herstatin), which can also be found in serum, is the product of an alternatively spliced HER2 transcript. Recent preclinical findings may provide crucial insights into the biological and clinical relevance of increased sHER2 concentrations for the outcome of HER2-positive breast cancer and sensitivity to trastuzumab and lapatinib treatment. We present here the most recent findings about the role and biology of sHER2 based on data obtained using a standardized test, which has been cleared by FDA in 2000, for measuring sHER2. This test includes quality control assessments and has been already widely used to evaluate the clinical utility of sHER2 as a biomarker in breast cancer. We will describe in detail data concerning the assessment of sHER2 as a surrogate maker to optimize the evaluation of the HER2 status of a primary tumor and as a prognosis and predictive marker of response to therapies, both in early and metastatic breast cancer.

Frame detection over the semantic web

In the past, research in ontology learning from text has mainly focused on entity recognition, taxonomy induction and relation extraction. In this work we approach a challenging research issue: detecting semantic frames from texts and using them to encode web ontologies. We exploit a new generation Natural Language Processing technology for frame detection, and we enrich the frames acquired so far with argument restrictions provided by a super-sense tagger and domain specializations. The results are encoded according to a Linguistic MetaModel, which allows a complete translation of lexical resources and data acquired from text, enabling custom transformations of the enriched frames into modular ontology components.

Pièces relatives à l'histoire de la ville de TULLE. V

Contient : Pièces relatives au procès soutenu par Jean Melon, syndic du clergé du diocèse de Tulle, demandeur en crime de faux, contre Joseph de Lespinasse, conseiller au siège présidial de ladite ville, relativement au testament de François de La Garde, élu de Tulle ; Testament, dudit F. de La Garde (7 février 1681) ; imprimé (Corda, Catal. des Factums, t. II, p. 337) ; Copie manuscrite du même testament et de pièces relatives à l'instance introduite par Jean Melon (avril 1684) ; Mémoire manuscrit adressé au Parlement par le même (s. d.) ; Pièces imprimées relatives à la même affaire ; Factum du procez par ledit J. Melon contre J.-J. de Lespinasse ; Observations sommaires sur le factum de M. de Lespinasse ; Procez verbal et raport des experts commis en cette affaire par le Parlement de Guyenne ; Factum pour M. J.-J. de Lespinasse contre M. R. Gaye, directeur du séminaire de Tulle, J. Melon et les héritiers ab intestat de Fr. de La Garde (30 août 1688) (Corda, Catal. des factums, t. III, p. 324) ; Réflexions de J. Melon sur le factum de J.-J. de Lespinasse (ibid.) ; Mémoire pour J. Melon et R. Gaye contre les héritiers de Fr. de La Garde ; Factum... servant de contredits pour M. R. Gaye contre Fr. de Saint-Priest (Corda, Cat. des Factums, t. II, p. 336) ; Mémoire particulier touchant la dépense de l'état du même (ibid.) ; Mémoire pour les maire et consuls de Tulle contre les héritiers de M. de La Garde et M. Melon (Corda, op. cit., t. VI, p. 193) ; Salvations pour Fr. de Saint-Priest et consorts contre Me Raymond Gaye ; Pièces manuscrites relatives au séminaire de Tulle : ; Arrêts de Parlement concernant les droits dudit séminaire dans l'affaire précédente (23 janvier-4 septembre 1692) ; Pièces concernant l'union du séminaire de Tulle à celui de Saint-Sulpice à Paris (28 mars 1697-19 juillet 1698) ; Mémoire sur les différends entre l'évêque de Tulle et l'hôpital général de ladite ville ; Procès-verbal de la réunion tenue audit hôpital le 11 juin 1696 ; Recueil de pièces imprimées concernant l'hôpital général de Tulle : ; Établissement d'un hôpital général dans la ville de Tulle par lettres patentes du mois de décembre 1670 (Tulle, 1687) ; Mémoire pour les administrateurs de l'hôpital de Tulle, contre M. Ancelin, évêque de cette ville (Corda, op. cit., t. VI, p. 193) ; Mémoire sur le même sujet, signé Melon (ibid.) ; Autre Mémoire sur le même sujet, signé Delarue (ibid.) ; Factum pour les doyen et chapitre de la cathédrale de Tulle, contre Gaspard Daudebert, curé de Salgues

Carte générale de la Turquie d'Europe à la droite du danube ou des beglerbegliks de Roum Jli, Bosna et Morée : dressée d'après les meilleurs observations astronomiques, itinéraires, cartes particulières, & reconnaissances existantes jusqu'à ce jour / par F. Guillaume de Vaudoncourt, ... ; K. Wimberger graviert ; die Gebürge gravirt v. I. Päringer ; In Stein gravirt von A. Falger u:L. Zertahelly in München ; beschrieben und die Gebirge gravirt v. L. Zertahelly

Échelle(s) : [1:1 337 000 environ], Lieues de France, de 25 au degré, 30 [= 9,8 cm]

Clinical Learning Environment and Supervision. Development and Validation of the CLES Evaluation Scale

The purpose of the study is: (1) to describe how nursing students' experienced their clinical learning environment and the supervision given by staff nurses working in hospital settings; and (2) to develop and test an evaluation scale of Clinical Learning Environment and Supervision (CLES). The study has been carried out in different phases. The pilot study (n=163) explored the association between the characteristics of a ward and its evaluation as a learning environment by students. The second version of research instrument (which was developed by the results of this pilot study) were tested by an expert panel (n=9 nurse teachers) and test-retest group formed by student nurses (n=38). After this evaluative phase, the CLES was formed as the basic research instrument for this study and it was tested with the Finnish main sample (n=416). In this phase, a concurrent validity instrument (Dunn & Burnett 1995) was used to confirm the validation process of CLES. The international comparative study was made by comparing the Finnish main sample with a British sample (n=142). The international comparative study was necessary for two reasons. In the instrument developing process, there is a need to test the new instrument in some other nursing culture. Other reason for comparative international study is the reflecting the impact of open employment markets in the European Union (EU) on the need to evaluate and to integrate EU health care educational systems. The results showed that the individualised supervision system is the most used supervision model and the supervisory relationship with personal mentor is the most meaningful single element of supervision evaluated by nursing students. The ward atmosphere and the management style of ward manager are the most important environmental factors of the clinical ward. The study integrates two theoretical elements - learning environment and supervision - in developing a preliminary theoretical model. The comparative international study showed that, Finnish students were more satisfied and evaluated their clinical placements and supervision with higher scores than students in the United Kingdom (UK). The difference between groups was statistical highly significant (p= 0.000). In the UK, clinical placements were longer but students met their nurse teachers less frequently than students in Finland. Arrangements for supervision were similar. This research process has produced the evaluation scale (CLES), which can be used in research and quality assessments of clinical learning environment and supervision in Finland and in the UK. CLES consists of 27 items and it is sub-divided into five sub-dimensions. Cronbach's alpha coefficient varied from high 0.94 to marginal 0.73. CLES is a compact evaluation scale and user-friendliness makes it suitable for continuing evaluation.

Long-term outcomes of pandemic 2009 influenza A(H1N1)-associated severe ARDS.

BACKGROUND: No data on long-term outcomes of survivors of 2009 influenza A(H1N1) (A[H1N1])-associated ARDS are available. The objective of this study was to compare the 1-year outcomes of survivors of A(H1N1)-associated ARDS, according to use or no use of extracorporeal lung assist (ECLA), using its need as an ARDS severity surrogate. METHODS: Survivors of ARDS (12 with ECLA use vs 25 without, corresponding to 75% and 54% of the eligible patients for each group, respectively) selected from the Réseau Européen de Ventilation Artificielle (REVA) registry had previously been healthy, with only pregnancy and/or moderate obesity (BMI ≤ 35 kg/m²) as known risk factors for A(H1N1) infection. Lung function and morphology, health-related quality of life (HRQoL), and psychologic impairment were evaluated. RESULTS: At 1 year post-ICU discharge for the ECLA and no-ECLA groups, respectively, 50% and 40% reported significant exertion dyspnea, 83% and 64% had returned to work, and 75% and 64% had decreased diffusion capacity across the blood-gas barrier, despite their near-normal and similar lung function test results. For both groups, exercise test results showed diminished but comparable exercise capacities, with similar alveolar-arterial oxygen gradients at peak exercise, and CT scans showed minor abnormal findings. HRQoL assessed by the 36-Item Short-Form Health Survey was poorer for both groups than for a sex- and age-matched general population group, but without between-group differences. ECLA and no-ECLA group patients, respectively, had symptoms of anxiety (50% and 56%) and depression (28% and 28%) and were at risk for posttraumatic stress disorder (41% and 44%). CONCLUSIONS: One year post-ICU discharge, a majority of survivors of A(H1N1)-associated ARDS had minor lung disabilities with diminished diffusion capacities across the blood-gas barrier, and most had psychologic impairment and poorer HRQoL than a sex- and age-matched general population group. ECLA and no-ECLA group patients had comparable outcomes. TRIAL REGISTRY: ClinicalTrials.gov; No.: NCT01271842; URL: www.clinicaltrials.gov

Brain natriuretic peptide is able to stimulate cardiac progenitor cell proliferation and differentiation in murine hearts after birth.

Brain natriuretic peptide (BNP) contributes to heart formation during embryogenesis. After birth, despite a high number of studies aimed at understanding by which mechanism(s) BNP reduces myocardial ischemic injury in animal models, the actual role of this peptide in the heart remains elusive. In this study, we asked whether BNP treatment could modulate the proliferation of endogenous cardiac progenitor cells (CPCs) and/or their differentiation into cardiomyocytes. CPCs expressed the NPR-A and NPR-B receptors in neonatal and adult hearts, suggesting their ability to respond to BNP stimulation. BNP injection into neonatal and adult unmanipulated mice increased the number of newly formed cardiomyocytes (neonatal: +23 %, p = 0.009 and adult: +68 %, p = 0.0005) and the number of proliferating CPCs (neonatal: +142 %, p = 0.002 and adult: +134 %, p = 0.04). In vitro, BNP stimulated CPC proliferation via NPR-A and CPC differentiation into cardiomyocytes via NPR-B. Finally, as BNP might be used as a therapeutic agent, we injected BNP into mice undergoing myocardial infarction. In pathological conditions, BNP treatment was cardioprotective by increasing heart contractility and reducing cardiac remodelling. At the cellular level, BNP stimulates CPC proliferation in the non-infarcted area of the infarcted hearts. In the infarcted area, BNP modulates the fate of the endogenous CPCs but also of the infiltrating CD45(+) cells. These results support for the first time a key role for BNP in controlling the progenitor cell proliferation and differentiation after birth. The administration of BNP might, therefore, be a useful component of therapeutic approaches aimed at inducing heart regeneration.

Clinical management of immunocompetent hospitalized patients with community-acquired pneumonia.

Background: Clinical practices and guidelines may differ regarding the management of inpatients with community-acquired pneumonia (CAP). Methods: The management of 152 consecutive CAP inpatients (70+/-17 years) admitted to a teaching hospital was analyzed retrospectively and compared with published data and an evidence-based guideline developed at our institution. Results: Of the patients studied, 64% had a high prognostic score index (PSI), 14% were admitted to the ICU, and 4.6% died. Initially, patients received either a one-drug (47%) or a two-drug (53%) antibiotic regimen. None of the 20 PSI parameters, and neither the PSI nor admission to the ICU, was associated with the initial antibiotic regimen. Agreement between current practice and our guideline was low (kappa=0.16). Following the recommendations would have led to a decrease of 51% in the initial two-drug regimen. The duration of i.v. antibiotherapy was higher in patients following the two-drug regimen (142+/-150 vs. 102+/-60 h, P<0.05). Chest physiotherapy (CP) and bronchodilatators (BD) were prescribed in 72% and 54% of cases, respectively (median duration 10 days). Conclusions: The variations observed in the clinical management of CAP inpatients were not in agreement with published guidelines. The overuse of a two-drug regimen, CP, and BD necessitates the development and implementation of evidence-based guidelines proposing detailed steps for the management of CAP inpatients.

Vitae sanctorum. Pars I. Saints du mois de janvier.

Agnes (184). - Ascla (205). - Babillus (206 v). - Balthildis regina (243 v). - Concordius (20). -Emerentiana (204). - Felix, 19 kl. febr. (105). - Firminus (101). - Fructuosus etc. (189). - Furseus (114). - Genovefa (21 v). - Hilarius (92). - Julianus et Bas. (67). - Leucus, Tyrsus et Galenicus (227). -Lutianus (62). - Macra (59). - Marcellus papa (107 v). - Martina (7 v). - Nicolaus (258 v). - Patroclus (190 v). - Paula (213 v). - Policarpus (209 v). - Quintinus (34 v). - Remigius (98). - Rigobertus (36 v). - Sabinianus (239 v). - Saturninus, Davitus etc. (142). - Sebastianus (154 v). - Speusipphus El. et Mel. (132 v). - Sulpitius (138 v). - Symeon (49 v). - Theogenius (32). - Timotheus (202 v). - Vincentius (194).